|
Market Closed -
Euronext Paris
00:55:00 29/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 0.8400 EUR | +0.72% |
|
+7.14% | +40.94% |
| 10-26 | Biosynex US Unit Bags $6 Million Award for DPP Biothreat Panel Assay Development | MT |
| 10-24 | A Biosynex subsidiary secures $5.7m in financing |  |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Diagnostic & Testing Substances
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 17.13M | - | - | - | - | - |
| 178B | |||||
| 116B | |||||
| 115B | |||||
| 93.1B | |||||
| 62.09B |
- Stock Market
- Stocks
- ALBIO Stock
- Charts Biosynex
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
